Introduction to Regulatory Affairs and Different Regulatory Bodies for Pharmaceutical Products and Impact of Digitalization on Regulatory Affairs — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Introduction to Regulatory Affairs and Different Regulatory Bodies for Pharmaceutical Products and Impact of Digitalization on Regulatory Affairs
Beijing Yisheng Biotechnology Co., Ltd., Beijing, China
,
Beijing Yisheng Biotechnology Co., Ltd., Beijing, China
1 Beijing Yisheng Biotechnology Co., Ltd., Beijing, China
2 Beijing Yisheng Biotechnology Co., Ltd., Beijing, China
To ensure the quality and marketability of products, the field of regulatory affairs (RA) serves as an intermediary between regulatory bodies, the industry, and consumers. The primary objective of pharmaceutical registration is centered on the marketing process. The World Health Organization (WHO), Pan American Health Organization (PAHO), World Trade Organization (WTO), International Conference on Harmonization (ICH), and World Intellectual Property Organization (WIPO) play crucial roles in the process. Drug registration and commercialization are overseen by national regulatory authorities initially, following the guidelines of the key organizations. The phenomenon of digital disruption is widespread and has significant effects on several domains of work. This influence has been further intensified by the COVID-19 epidemic, as well as the rapid advancements in the complexity and capabilities of machine learning and artificial intelligence algorithms. The future of this profession is influenced by various trends, including the swift progress in scientific comprehension of diseases, which has resulted in the emergence of novel therapeutic approaches for the treatment and potential eradication of some ailments. The importance of strategic collaborations, alignment, and integration among national regulatory agencies has been heightened by recent global regulatory reforms. This trend is expected to persist. The impact of these elements on regulatory professionals, medication development, and medical practice in the future is a subject of considerable attention. The enhancement of skills and the adoption of a growth mindset are crucial for regulatory affairs professionals to implement the necessary adjustments. This emerging paradigm promotes the cultivation of personal responsibility in individuals’ professional development, fostering adaptability and emphasizing the significance of lifelong learning. Through their actions, these specialists could exert influence on the process of product development, so contributing to the improvement of their society.
KeywordsDrug Regulatory AuthoritiesFuture TrendsCentralization of the Regulatory Authorities
Hoos, A., Anderson, J., Boutin, M., Dewulf, L., Geissler, J., Johnston, G., Joos, A., Metcalf, M., Regnante, J., Sargeant, I., Schneider, R.F., Todaro, V. and Tougas, G. (2015) Partnering with Patients in the Development and Lifecycle of Medicines: A Call for Action. Therapeutic Innovation & Regulatory Science, 49, 929-939. https://doi.org/10.1177/2168479015580384
Askin, S., Burkhalter, D., Calado, G. and El Dakrouni, S. (2023) Artificial Intelligence Applied to Clinical Trials: Opportunities and Challenges. Health and Technology, 13, 203-213. https://doi.org/10.1007/s12553-023-00738-2
Swift, B., Jain, L., White, C., Chandrasekaran, V., Bhandari, A., Hughes, D.A. and Jadhav, P.R. (2018) Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient Care. Clinical and Translational Science, 11, 450-460. https://doi.org/10.1111/cts.12559
El Zarrad, M.K., Lee, A.Y., Purcell, R. and Steele, S.J. (2022) Advancing an Agile Regulatory Ecosystem to Respond to the Rapid Development of Innovative Technologies. Clinical and Translational Science, 15, 1332-1339. https://doi.org/10.1111/cts.13267
Dance, A. (2013) Regulatory Science: Researchers in the Pipeline. Nature, 498, 387-389. https://doi.org/10.1038/nj7445-387a
Dhulichand, R. and Harish, D. (2010) New Drug Approval Process: Regulatory View. Pharmaceutical Reviews, 8.
Ayati, N., Saiyarsarai, P. and Nikfar, S. (2020) Short and Long Term Impacts of COVID-19 on the Pharmaceutical Sector. DARU Journal of Pharmaceutical Sciences, 28, 799-805. https://doi.org/10.1007/s40199-020-00358-5
Sagramoso, D. (2020) The COVID-19 Pandemic: Global Socio-Economic and Geopolitical Implications. New Perspectives, 28, 462-473. https://doi.org/10.1177/2336825X20955132
Gereffi, G. (2020) What Does the COVID-19 Pandemic Teach Us about Global Value Chains? The Case of Medical Supplies. Journal of International Business Policy, 3, 287-301. https://doi.org/10.1057/s42214-020-00062-w
Kirkpatrick, P.J. (2022) Artificial Intelligence Makes a Splash in Small-Molecule Drug Discovery. Biopharma Dealmakers. https://doi.org/10.1038/d43747-022-00104-7
Jumper, J., Evans, R., Pritzel, A., et al. (2021) Highly Accurate Protein Structure Prediction with AlphaFold. Nature, 596, 583-589. https://doi.org/10.1038/s41586-021-03819-2
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Zídek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S.A.A., Ballard, A.J., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., Back, T., Petersen, S., Reiman, D., Clancy, E., Zielinski, M., Steinegger, M., Pacholska, M., Berghammer, T., Bodenstein, S., Silver, D., Vinyals, O., Senior, A.W., Kavukcuoglu, K., Kohli, P. and Hassabis, D. (2021) Highly Accurate Protein Structure Prediction with AlphaFold. Nature, 596, 583-589. https://doi.org/10.1038/s41586-021-03819-2
Chrienová, O., Rysanek, D., Oleksák, P., Stary, D., Bajda, M., Reinis, M., Mikysková, R., Novotny, O., Andrys, R., Skarka, A., Vasicová, P., Novak, J.F., Valis, M., Kuca, K., Hodny, Z. and Nepovimová, E. (2022) Discovery of Small Molecule Mechanistic Target of Rapamycin Inhibitors as Anti-Aging and Anti-Cancer Therapeutics. Frontiers in Aging Neuroscience, 14, Article 1048260. https://doi.org/10.3389/fnagi.2022.1048260
Abbott, K.W. (2013) Introduction: The Challenges of Oversight for Emerging Technologies. In: Marchant, G.E., Abbott, K.W. and Allenby, B., Eds., Innovative Governance Models for Emerging Technologies, Edward Elgar Publishing, Cheltenham, 1-16. https://doi.org/10.4337/9781782545644.00006
Li, F. (2020) Leading Digital Transformation: Three Emerging Approaches for Managing the Transition. International Journal of Operations & Production Management, 40, 809-817. https://doi.org/10.1108/IJOPM-04-2020-0202
Magableh, G.M. (2021) Supply Chains and the COVID‐19 Pandemic: A Comprehensive Framework. European Management Review, 18, 363-382. https://doi.org/10.1111/emre.12449
Shah, P., Kendall, F., Khozin, S., Goosen, R., Hu, J., et al. (2019) Artificial Intelligence and Machine Learning in Clinical Development: A Translational Perspective. npj Digital Medicine, 2, Article No. 69. https://doi.org/10.1038/s41746-019-0148-3
Marble, H.D., Huang, R., Dudgeon, S.N., Lowe, A., et al. (2020) A Regulatory Science Initiative to Harmonize and Standardize Digital Pathology and Machine Learning Processes to Speed Up Clinical Innovation to Patients. Journal of Pathology Informatics, 11, Article 22. https://doi.org/10.4103/jpi.jpi_27_20
Wichmann, J.L., Willemink, M.J. and De Cecco, C.N. (2020) Artificial Intelligence and Machine Learning in Radiology: Current State and Considerations for Routine Clinical Implementation. Investigative Radiology, 55, 619-627. https://doi.org/10.1097/RLI.0000000000000673
Vives, X. (2019) Digital Disruption in Banking. Annual Review of Financial Economics, 11, 243-272. https://doi.org/10.1146/annurev-financial-100719-120854
Palmié, M., Wincent, J., Parida, V. and Caglar, U. (2020) The Evolution of the Financial Technology Ecosystem: An Introduction and Agenda for Future Research on Disruptive Innovations in Ecosystems. Technological Forecasting and Social Change, 151, Article 119779. https://doi.org/10.1016/j.techfore.2019.119779
Wewege, L., Lee, J. and Thomsett, M.C. (2020) Disruptions and Digital Banking Trends. Journal of Applied Finance & Banking, 10, 1-2.
European Medicines Agency (2015) Substance, Product, Organisation and Referential (SPOR) Master Data. https://www.ema.europa.eu/en/human-regulatory-overview/research-development/data-medicines-iso-idmp-standards-overview/substance-product-organisation-referential-spor-master-data
Khalil, R., Macdonald, J.C., Gustafson, A., Aljuburi, L., Bisordi, F. and Beakes-Read, G. (2023) Walking the Talk in Digital Transformation of Regulatory Review. Frontiers in Medicine, 10, Article 1233142. https://doi.org/10.3389/fmed.2023.1233142
National Academies of Sciences, Engineering, and Medicine (2020) Regulating Medicines in a Globalized World: The Need for Increased Reliance among Regulators. The National Academies Press, Washington, D.C.
Bolislis, W.R., Lucia, M.L., Dolz, F., Mo, R., Nagaoka, M., Rodriguez, H., et al. (2021) Regulatory Agilities in the Time of COVID-19: Overview, Trends, and Opportunities. Clinical Therapeutics, 43, 124-139. https://doi.org/10.1016/j.clinthera.2020.11.015
Zerhouni, E. and Hamburg, M. (2016) The Need for Global Regulatory Harmonization: A Public Health Imperative. Science Translational Medicine, 8, 338ed6. https://doi.org/10.1126/scitranslmed.aaf1396
Lezotre, P. (2014) International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations: A Global Perspective. Academic Press, Oxford.
International Council for Harmonisation (2022) International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Guideline Implementation. https://www.ich.org/page/ich-guideline-implementation
O’Brien, J., Lumsden, R.S. and Macdonald, J. (2021) Strengthening Regulatory Systems for Medicines in a Changed World: Where Do We Go from Here? BMJ Global Health, 6, e004680. https://doi.org/10.1136/bmjgh-2020-004680
Kiyohito, N., Araki, Y., Ebina, D., Watanabe, T., Tanaka, Y. and Toyoshima, S. (2009) Electronic Common Technical Document Implementation in Japan, Drug Information Journal: DIJ/Drug Information Association, 43, 395-401. https://doi.org/10.1177/009286150904300402
Andreas, S. and Ostermann, H. (2012) The Electronic Common Technical Document (eCTD): An International pro/con Analysis of the Pharmaceutical Product Electronic Submission Process. Drug Information Journal: DIJ/Drug Information Association, 46, 124-139. https://doi.org/10.1177/0092861511427871
Molzon, J.A., Giaquinto, A., Lindstrom, L., Tominaga, T., Ward, M., Doerr, P., Hunt, L. and Rago, L. (2011) The Value and Benefits of the International Conference on Harmonisation to Drug Regulatory Authorities: Advancing Harmonization for Better Public Health. Clinical Pharmacology and Therapeutics, 89, 503-512. https://doi.org/10.1038/clpt.2011.10
Yan, K., Balijepalli, C. and Druyts, E. (2021) The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks. Frontiers in Digital Health, 3, Article 667016. https://doi.org/10.3389/fdgth.2021.667016
Algorri, M., Cauchon, N. and Abernathy, M. (2020) Transitioning Chemistry, Manufacturing, and Controls Content with a Structured Data Management Solution: Streamlining Regulatory Submissions. Journal of Pharmaceutical Sciences, 109, 1427-1438. https://doi.org/10.1016/j.xphs.2020.01.020
Arden, N.S., Fisher, A.C., Tyner, K., Yu, L.X., Lee, S.L. and Kopcha, M. (2021) Industry 4.0 for Pharmaceutical Manufacturing: Preparing for the Smart Factories of the Future. International Journal of Pharmaceutics, 602, Article 120554. https://doi.org/10.1016/j.ijpharm.2021.120554
Busuioc, M. (2022) Chapter 31: AI Algorithmic Oversight: New Frontiers in Regulation. In: Maggetti, M., Di Mascio, F. and Natalini, A., Eds., Handbook of Regulatory Authorities, Edward Elgar Publishing, Cheltenham, 470-486. https://doi.org/10.4337/9781839108990.00043
Bruckner, M.A. (2022) Artificial Intelligence and Machine Learning: The Opportunities and Challenges of Using Big Data. In: Jeng, L., Ed., Open Banking, Oxford Academic, New York, 75-C4.N1. https://doi.org/10.1093/oso/9780197582879.003.0005
Harvey, H. and Gowda, V. (2021) Regulatory Issues and Challenges to Artificial Intelligence Adoption. Radiologic Clinics, 59, 1075-1083. https://doi.org/10.1016/j.rcl.2021.07.007
Santosh, G. (2024) Building Inclusive AI: Addressing Bias and Promoting Fairness. https://www.linkedin.com/pulse/building-inclusive-ai-addressing-bias-promoting-fairness-santosh-g-m4s4c/
Fischer, B. and Piskorz-Ryń, A. (2021) Artificial Intelligence in the Context of Data Governance. International Review of Law, Computers & Technology, 35, 419-428. https://doi.org/10.1080/13600869.2021.1950925
Schneider, J., Abraham, R., Meske, C. and Brocke, J.V. (2022) Artificial Intelligence Governance for Businesses. Information Systems Management, 40, 229-249. https://doi.org/10.1080/10580530.2022.2085825
Janssen, M., Brous, P., Estevez, E., Barbosa, L.S. and Janowski, T. (2020) Data Governance: Organizing Data for Trustworthy Artificial Intelligence. Government Information Quarterly, 37, Article 101493. https://doi.org/10.1016/j.giq.2020.101493
Simao, J.P. and Belo, O. (2018) A Step Foreword Historical Data Governance. Information Systems, Limassol, 4-5 October 2018, 80-90. https://doi.org/10.1007/978-3-030-11395-7_8
Ciuriak, D. and Ptashkina, M. (2020) Toward a Robust Architecture for the Regulation of Data and Digital Trade. Centre for International Governance Innovation, No. 240. https://doi.org/10.2139/ssrn.3423394
World Health Organization (2024) Ethics and Governance of Artificial Intelligence for Health: Guidance on Large Multi-Modal Models: World Health Organization.
Ahmad, T. (2019) Scenario Based Approach to Re-Imagining Future of Higher Education Which Prepares Students for the Future of Work. Higher Education, Skills and Work-Based Learning, 10, 217-238. https://doi.org/10.1108/HESWBL-12-2018-0136
Giles, C. (2022) Next Gen Strategies: A Playbook. In: Giles, C., Ed., Next Generation Compliance: Environmental Regulation for the Modern Era, Oxford University Press, Oxford, 121-158. https://doi.org/10.1093/oso/9780197656747.003.0006
Sharma, S. (2022) Regulations 4.0: Digitally Transforming the Regulatory Space. In: Goswami, S., Barara, I.S., Goje, A., Mohan, C. and Bruckstein, A.M., Eds., Data Management, Analytics and Innovation, Springer, Singapore, 345-353. https://doi.org/10.1007/978-981-19-2600-6_24
Fahy, L.A. (2022) Regulator Reputation and the Successful Governance of Innovation. Ph.D. Thesis, Utrecht University Repository, Utrecht.
Christofi, M., Pereira, V., Vrontis, D., Tarba, S.Y. and Thrassou, A. (2021) Agility and Flexibility in International Business Research: A Comprehensive Review and Future Research Directions. Journal of World Business, 56, Article 101194. https://doi.org/10.1016/j.jwb.2021.101194
Chisholm, O. and Critchley, H. (2023) Future Directions in Regulatory Affairs. Frontiers in Medicine, 9, Article 1082384. https://doi.org/10.3389/fmed.2022.1082384
Lalot, F., Falomir-Pichastor, J.M. and Quiamzade, A. (2021) Regulatory Focus and Self-Licensing Dynamics: A Motivational Account of Behavioural Consistency and Balancing. Journal of Environmental Psychology, 79, Article 101731. https://doi.org/10.1016/j.jenvp.2021.101731
Bucu, A.S. (2022) Enhancing the Problem-Solving and Critical Thinking Skills of Students Using the Mathematical Investigation Approach. Studies in Technology and Education, 1, 28-36. https://doi.org/10.55687/ste.v1i1.19
Drago, D., McDonald, P. and Lotrecchiano, G.R. (2018) Communicating Transdisciplinary Characteristics in Global Regulatory Affairs: An Example from Health Professions Education. Informing Science Informing Science: The International Journal of an Emerging Transdiscipline, 21, 219-234. https://doi.org/10.28945/4030
Gill, D. (2016) Defining Regulatory Management Systems. In: Gill, D. and Intal Jr., P., Eds., The Development of Regulatory Management Systems in East Asia: Country Studies, Economic Research Institute for ASEAN and East Asia, Jakarta, 3-19.
Pahlow, L. and Schneider, M. (2019) Global Flows of Knowledge: Expectations toward Transnational Regulatory Aspects of Intellectual Property Rights in the 20th Century Chemical Industry. Management & Organizational History, 14, 350-365. https://doi.org/10.1080/17449359.2019.1683034
Batista, P.M. and Ringe, W.-G. (2020) Dynamism in Financial Market Regulation: Harnessing Regulatory and Supervisory Technologies. https://doi.org/10.2139/SSRN.3711618
Allen, D.W.E. and Berg, C. (2018) Regulation and Technological Change. In: Allen, D.W.E. and Berg, C., Eds., Australia’s Red Tape Crisis, Connor Court Publishing, Australia. https://ssrn.com/abstract=3140921